Zum Hauptinhalt springen

Hepatitiden

06. Oktober 2020 | Hepatitiden

EASL Recommendations on Treatment of Hepatitis C 2020

EASL Recommendations on Treatment of Hepatitis C 2020 This final update of the EASL Recommendations on Treatment of Hepatitis C series is intended to assist physicians and other healthcare providers, as well as patients and other interested indiv...

13. September 2020 | Hepatitiden

EASL Policy Statement: Drug use and the global hepatitis elimination goal

EASL Policy Statement: Drug use and the global hepatitis elimination goal (European Association for the Study of the Liver, 2020) https://easl.eu/wp-content/uploads/2020/08/full-version-easl-policy-statement-on-drug-use-and-the-global-hepa...

06. September 2020 | Hepatitiden

The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.

The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review. Seval N, Wurcel A, Gunderson CG, Grimshaw A, Springer SA. Infect Dis Clin North Am. 2020;34(3):559-584. doi:1...

05. September 2020 | Hepatitiden

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017.

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017. Aas CF, Vold JH, Skurtveit S, et al. BMJ Open. 2020;10(8):e0...

05. September 2020 | Hepatitiden

Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection.

Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection. Ashhab AA, Rodin H, Campos M, Abu-Sulb A, Hall JA, Powell J, et al. (2020) PLoS ONE 15(8): e0237398. doi.org/10.1371/journal.pone.0237...

05. September 2020 | Hepatitiden

Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination.

Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination. Akiyama MJ. BMC Med. 2020;18(1):208. Published 2020 Aug 14. doi:10.1186/s12916-020-01680-0 https://www.ncbi.nlm.n...

05. September 2020 | Hepatitiden

Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma.

Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma. Lin WC, Lin YS, Chang CW, et al. PLoS One. 2020;15(5):e0233212. Published 2020 May 22. doi:10.1371/journal.pone.0233212 https://journals.plo...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten